Twister Biotech, Inc. — Form D
Twister Biotech, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-28. The offering totals $2.0M, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-28
- Form: D
- Accession: 0001716382-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $500K
- Remaining: $1.5M
- Minimum investment: $5K
- Investors: 2
- Date of first sale: 2023-08-25
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-490804
Issuer
- Name: Twister Biotech, Inc.
- CIK: 0001716382
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4108 LILLIAN ST., UNIT B, HOUSTON, TX, 77007
- Phone: 832-236-1326
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Christopher Coker | Director | Houston, TX |
| Evan Davies | Director | London, X0 |
| Michael Pavia | Director | Houston, TX |
| Alex Steven | Director | Houston, TX |
| Christopher Coker | Executive Officer | Houston, TX |
| Alex Steven | Executive Officer | Houston, TX |
| Mark Matovich | Director | Houston, TX |
| Lynn Zechiedrich | Director | Houston, TX |
| Lynn Zechiedrich | Executive Officer | Houston, TX |
Other filings by this issuer (1)
More